Nasdaq Marketsmarketsinvestment opinion
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? (opens at Nasdaq Markets in a new tab)
The article compares BioNTech and Moderna as potential cancer vaccine investments. Both companies are no longer generating significant revenue from their coronavirus vaccines.
